Health
New Alzheimer’s drug aducanumab is dividing doctors and patients, as the TGA weighs up its risk-benefit profile – ABC News
The first new Alzheimer’s drug approved by US regulators in almost two decades is generating global interest and global controversy….
After a decades-long career as a biology teacher, John Rodgers applies the strict logic of a scientist to answer tough questions.
So, when it comes to his mortality, he is equally rational.
“I either want it to end quickly or get better,” he said.
Key points:
…
Continue Reading
-
Noosa News20 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business23 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
Noosa News22 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
General21 hours agoInternal Revenue Service starts cutting 20,000 workers